Product Information
TOBRAMYCIN-DEXAMETH OPHTH SUSP is a generic product labeled by Bausch & Lomb Incorporated, priced at $4.6249 per ML under NDC 24208029525. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 27, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1; 3 mg/mL; mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208029525
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
DEXAMETHASONE; TOBRAMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA064134FDA Approved
10/27/1999
TE Code
AB
On Market Since
10/27/1999
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 73.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6249 per ML |
|---|---|
| All-time high | $18.1894 (Jan 15, 2014) |
| All-time low | $4.4089 (Dec 17, 2025) |
| 52-week high | $6.6531 |
| 52-week low | $4.4089 |
| Median price | $14.8418 |
| Average price | $12.8047 |
| Largest weekly change | -44.9% (Jul 17, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOBRAMYCIN-DEXAMETH OPHTH SUSP?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN-DEXAMETH OPHTH SUSP, manufactured by Bausch & Lomb Incorporated, is $4.6249 per ML (NDC 24208029525), effective Aug 19, 2026.
How has the price of TOBRAMYCIN-DEXAMETH OPHTH SUSP changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has declined 73.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN-DEXAMETH OPHTH SUSP?
Since Nov 28, 2013, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has ranged from a low of $4.4089 (Dec 17, 2025) to a high of $18.1894 (Jan 15, 2014), with a median of $14.8418 per ML.
Are there cheaper alternatives to TOBRAMYCIN-DEXAMETH OPHTH SUSP?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOBRAMYCIN-DEXAMETH OPHTH SUSP, is $4.2681 per ML — about 8% below TOBRAMYCIN-DEXAMETH OPHTH SUSP.
Who manufactures TOBRAMYCIN-DEXAMETH OPHTH SUSP?
TOBRAMYCIN-DEXAMETH OPHTH SUSP (NDC 24208029525) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.